Wells Fargo & Company Abvc Biopharma, Inc. Transaction History

Wells Fargo & Company

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$0.5 - $0.92 $3 - $6	7 Added 5.74%	129 $0
Q1 2023 May 12, 2023	BUY	$0.57 - $1.07 $1 - $2	2 Added 1.67%	122 $0
Q4 2022 Feb 13, 2023	BUY	$0.62 - $9.1 $2 - $36	4 Added 3.45%	120 $0
Q3 2022 Nov 14, 2022	BUY	$0.52 - $8.9 $60 - $1,032	116 New	116 $0

Ticker ABVC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,632,300
Market Cap $22.8M
Description
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major dep...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.